Abstract
Purpose. Heparin and low-molecular weight heparin (LMWH) are the most commonly used anticoagulants and are administered by intravenous or subcutaneous injections. However, injections of heparin have the potential risk of bleeding complications and the requirement of close monitoring in some cases. We hypothesized that transdermal delivery of heparin may provide an attractive alternative to injections. However, the dose of transdermally delivered heparin is limited by low skin permeability.
Methods. We increased skin permeability to heparin and LMWH using low-frequency (20 kHz) ultrasound. Biologic activity of transdermally delivered heparin was measured by using activated clotting time assays and by using anti-Xa (aXa) activity. Structural integrity of heparin was also assessed by using gel electrophoresis.
Results. Low-frequency ultrasound increased permeability of pigskin in vitro and rat skin in vivo and allowed delivery of biologically active doses of heparin and low-molecular weight heparin transdermally. A prolonged contact of transdermally delivered heparin with pigskin was found to reduce the biologic activity of heparin, although no such deactivation was observed during short exposures. Transdermally delivered LMWH resulted in sustained aXa levels in the blood. This result was in strong contrast to subcutaneous or intravenous injections of LMWH, which resulted in only temporary elevations of aXa level.
Conclusions. Transdermal delivery of low-molecular weight heparin is a potential alternative to injections.
Similar content being viewed by others
REFERENCES
A. Frydman. Low-molecular weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humans. Hemastatis. 26:24-38 (1996).
R. L. Bronaugh and H. I. E. Maibach. Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery, Marcel Dekker, New York, 1989.
M. R. Prausnitz, E. R. Edleman, J. A. Gimm, R. Langer, and J. C. Weaver. Transdermal delivery of heparin by skin electroporation. Biotechnology 13:1205-1209 (1995).
S. Mitragotri, D. Blankschtein, and R. Langer. Ultrasound-mediated transdermal protein delivery. Science 269:850-853 (1995).
S. Mitragotri, D. Edwards, D. Blankschtein, and R. Langer. A mechanistic study of ultrasonically enhanced transdermal drug delivery. J. Pharm. Sci. 84:697-706 (1995).
D. Bommannan, H. Okuyama, P. Stauffer, and R. H. Guy. Sonophoresis. I. The use of high-frequency ultrasound to enhance transdermal drug delivery. Pharm. Res. 9:559-564 (1992).
D. Bommannan, G. K. Menon, H. Okuyama, P. M. Elias, and R. H. Guy. Sonophoresis. II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery. Pharm. Res. 9:1043-1047 (1992).
K. Tachibana. Transdermal delivery of insulin to alloxan-diabetc rabbits by ultrasound exposure. Pharm. Res. 9:952-954 (1992).
S. Mitragotri, D. Ray, J. Farrell, H. Tang, B. Yu, J. Kost, D. Blankschtein, and R. Langer. Synergistic effect of ultrasound and sodium lauryl sulfate on transdermal drug delivery. J. Pharm. Sci. 89:892-900 (2000).
S. Mitragotri and J. Kost. Low-frequency sonophoresis: a non-invasive method for drug delivery and diagnostics. Biotech. Prog. 16:488-492 (2000).
S. Mitragotri, J. Farrell, H. Tang, Terahara, J. Kost, and R. Langer. Determination of the threshold energy dose for ultrasound-induced transdermal drug delivery. J. Control. Release 63:41-52 (2000).
R. E. Edens, A. al-Hakim, J. M. Weiler, D. G. Rethwisch, J. Fareed, and R. Linhardt. Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular weight heparin derivatives. J. Pharm. Sci. 81:823-827 (1992).
J. Kost, S. Mitragotri, R. Gabbay, M. Pishko, and R. Langer. Transdermal extraction of glucose and other analytes using ultrasound. Nat. Med. 6:347-350 (2000).
D. Lane and U. Lindhal. Heparin: Chemical and Biological Properties, Clinical Applications, CRC Press, Boca Raton, 1989.
L. Piazolo, J. Harenberg, R. Malsch, F. Huttner, and D. Heene. Comparison of the pharmacodynamic and pharmacokinetic profiles of two low-molecular-mass heparins in rats. Semin. Thromb. Hemost. 23:109-117 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mitragotri, S., Kost, J. Transdermal Delivery of Heparin and Low-Molecular Weight Heparin Using Low-Frequency Ultrasound. Pharm Res 18, 1151–1156 (2001). https://doi.org/10.1023/A:1010979010907
Issue Date:
DOI: https://doi.org/10.1023/A:1010979010907